Document is current

Article History

Received: 18 December 2020

Accepted: 22 March 2021

First Online: 25 April 2021

Declarations

:

: Ethical approval was provided by the International Medical University Malaysia (IMU) Joint-Committee on Research and Ethics (Project ID No: IMU R 175/2015) and the University of Southampton Faculty of Medicine Ethics Committee (Submission ID: 14478). Facilitated by translators throughout, a process for gaining informed consent was followed for all participants, with parents/guardians providing consent for those under 18 years. Participation involved reading and understanding the study information sheet and the completion of a consent form and questionnaire. In cases of poor literacy, study paperwork was read to participants, and consent forms signed to the best of the participant’s ability with support from literate family members.

: SCC acts as principal investigator on studies conducted on behalf of University Hospital Southampton NHS Foundation Trust/University of Southampton that are sponsored by vaccine manufacturers but receives no personal payments from them. SCC has participated in advisory boards for vaccine manufacturers but receives no personal payments for this work. SCC has received financial assistance from vaccine manufacturers to attend conferences. DWC was a post-doctoral researcher on projects funded by Pfizer and GSK between April 2014 and October 2017. All grants and honoraria are paid into accounts within the respective NHS Trusts or Universities, or to independent charities. All other authors have no conflicts of interest.